These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7578391)

  • 1. Preclinical pharmacokinetics, manufacturing, and safety studies supporting a multicenter cancer gene therapy trial.
    Norman JA; Parker S; Lew D; Manthorpe M; Marquet M
    Hum Gene Ther; 1995 May; 6(5):549-50. PubMed ID: 7578391
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.
    Bergen M; Chen R; Gonzalez R
    Expert Opin Biol Ther; 2003 Apr; 3(2):377-84. PubMed ID: 12662150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.
    Rini BI; Selk LM; Vogelzang NJ
    Clin Cancer Res; 1999 Oct; 5(10):2766-72. PubMed ID: 10537340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
    Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trial.
    Gleich LL; Gluckman JL; Armstrong S; Biddinger PW; Miller MA; Balakrishnan K; Wilson KM; Saavedra HI; Stambrook PJ
    Arch Otolaryngol Head Neck Surg; 1998 Oct; 124(10):1097-104. PubMed ID: 9776187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.
    Horn NA; Meek JA; Budahazi G; Marquet M
    Hum Gene Ther; 1995 May; 6(5):565-73. PubMed ID: 7578394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic therapy targeting metastatic melanoma: allovectin-7.
    Chowdhery R; Gonzalez R
    Immunotherapy; 2011 Jan; 3(1):17-21. PubMed ID: 21174553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology evaluation: Allovectin-7, Vical.
    Galanis E
    Curr Opin Mol Ther; 2002 Feb; 4(1):80-7. PubMed ID: 11883699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
    Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
    Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Velimogene aliplasmid.
    Soares HP; Lutzky J
    Expert Opin Biol Ther; 2010 May; 10(5):841-51. PubMed ID: 20367461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice.
    Lew D; Parker SE; Latimer T; Abai AM; Kuwahara-Rundell A; Doh SG; Yang ZY; Laface D; Gromkowski SH; Nabel GJ
    Hum Gene Ther; 1995 May; 6(5):553-64. PubMed ID: 7578393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution of the cytofectin component of a plasmid-DNA/cationic lipid complex following intravenous administration in mice.
    Parker SE; Ducharme S; Norman J; Wheeler CJ
    Hum Gene Ther; 1997 Mar; 8(4):393-401. PubMed ID: 9054514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allovectin-7 therapy in metastatic melanoma.
    Bedikian AY; Del Vecchio M
    Expert Opin Biol Ther; 2008 Jun; 8(6):839-44. PubMed ID: 18476795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human gene therapy for melanoma: CT-guided interstitial injection.
    Waddill W; Wright W; Unger E; Stopeck A; Akporiaye E; Harris D; Grogan T; Schluter S; Hersh E; Stahl S
    AJR Am J Roentgenol; 1997 Jul; 169(1):63-7. PubMed ID: 9207502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
    Stopeck AT; Hersh EM; Akporiaye ET; Harris DT; Grogan T; Unger E; Warneke J; Schluter SF; Stahl S
    J Clin Oncol; 1997 Jan; 15(1):341-9. PubMed ID: 8996161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.
    Stopeck AT; Jones A; Hersh EM; Thompson JA; Finucane DM; Gutheil JC; Gonzalez R
    Clin Cancer Res; 2001 Aug; 7(8):2285-91. PubMed ID: 11489803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
    Salamone FN; Gleich LL; Li YQ; Stambrook PJ
    Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vical updates Allovectin-7 melanoma program.
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):481-2. PubMed ID: 12382510
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy for cancer by direct gene transfer into tumors.
    Nabel GJ; Chang AE; Nabel EG; Plautz GE; Ensminger W; Fox BA; Felgner P; Shu S; Cho K
    Hum Gene Ther; 1994 Jan; 5(1):57-77. PubMed ID: 8155772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.